UK Markets close in 8 hrs 18 mins

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.20-0.52 (-1.22%)
At close: 04:00PM EST
42.20 0.00 (0.00%)
After hours: 04:15PM EST
Full screen
Trade prices are not sourced from all markets
Previous close42.72
Open42.62
Bid0.00 x 1100
Ask0.00 x 800
Day's range41.50 - 43.31
52-week range29.88 - 127.20
Volume786,973
Avg. volume854,232
Market cap2.261B
Beta (5Y monthly)0.98
PE ratio (TTM)5.93
EPS (TTM)7.12
Earnings date16 Feb 2022 - 21 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est85.71
  • Reuters

    Canada clears import of J&J COVID-19 vaccine doses made at Emergent plant

    The decision, Health Canada said, came after it had completed an inspection of the facility in Baltimore, Maryland, along with the European Medicines Agency and South African Health Products Regulatory Authority. The beleaguered facility has been under regulatory scrutiny since a manufacturing error earlier this year ruined millions of doses of J&J's COVID-19 vaccine. Canada in June said it would not accept any doses made at the plant until it completed its own on-site inspection.

  • Motley Fool

    Why Emergent BioSolutions Popped by Over 4% Today

    Such is the case with vaccine and antibody company Emergent BioSolutions (NYSE: EBS), which closed Friday more than 4% higher after it announced it would open its wallet to buy shares of its own equity. Emergent BioSolutions is launching a fresh share-buyback program under which management is authorized to repurchase as much as $250 million worth of its common stock. As of Sept. 30, it held cash and cash equivalents totaling nearly $404 million.

  • Simply Wall St.

    Are Investors Undervaluing Emergent BioSolutions Inc. (NYSE:EBS) By 43%?

    How far off is Emergent BioSolutions Inc. ( NYSE:EBS ) from its intrinsic value? Using the most recent financial data...